GABA B receptor

From WikiMD's Wellness Encyclopedia

GABAB Receptor[edit | edit source]

The GABAB receptor is a type of GABA receptor that is metabotropic, meaning it is a G-protein coupled receptor (GPCR). It is one of the two main types of receptors for gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system (CNS). Unlike the ionotropic [[GABAA receptor]], which directly mediates fast synaptic inhibition, the GABAB receptor mediates slower, prolonged inhibitory signals.

Structure[edit | edit source]

The GABAB receptor is a heterodimer composed of two subunits: GABAB1 and GABAB2. These subunits are necessary for the receptor's function and are linked together to form a functional receptor complex. The GABAB1 subunit is responsible for binding GABA, while the GABAB2 subunit is essential for G-protein coupling and signal transduction.

Mechanism of Action[edit | edit source]

Upon binding of GABA to the GABAB receptor, a conformational change occurs, activating the associated G-proteins. This activation leads to the inhibition of adenylate cyclase, a decrease in cyclic AMP (cAMP) levels, and the opening of potassium channels while closing calcium channels. The result is hyperpolarization of the neuron, making it less likely to fire an action potential, thus exerting an inhibitory effect.

Physiological Role[edit | edit source]

GABAB receptors are widely distributed in the brain and spinal cord. They play a crucial role in modulating synaptic transmission, neuronal excitability, and synaptic plasticity. These receptors are involved in various physiological processes, including:

Clinical Significance[edit | edit source]

GABAB receptors are implicated in several neurological and psychiatric disorders. Dysregulation of GABAB receptor function has been associated with conditions such as:

Pharmacology[edit | edit source]

Agonists and antagonists of the GABAB receptor are of significant interest in pharmacology. Baclofen, a GABAB receptor agonist, is used clinically as a muscle relaxant and in the treatment of spasticity. Research is ongoing to develop more selective drugs targeting these receptors for therapeutic purposes.

See Also[edit | edit source]

References[edit | edit source]

  • Bowery, N. G., & Enna, S. J. (2000). "Gamma-aminobutyric acidB receptors: first of the functional metabotropic heterodimers." *Journal of Pharmacology and Experimental Therapeutics*, 292(1), 2-7.
  • Bettler, B., Kaupmann, K., Mosbacher, J., & Gassmann, M. (2004). "Molecular structure and physiological functions of GABAB receptors." *Physiological Reviews*, 84(3), 835-867.
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD